Biotest Aktiengesellschaft (ETR:BIO – Get Free Report)’s stock price shot up 0.5% on Friday . The stock traded as high as €41.80 ($44.95) and last traded at €41.80 ($44.95). 100 shares traded hands during trading, a decline of 95% from the average session volume of 1,927 shares. The stock had previously closed at €41.60 ($44.73).
Biotest Aktiengesellschaft Price Performance
The firm has a fifty day moving average price of €42.04 and a two-hundred day moving average price of €42.28. The company has a quick ratio of 1.66, a current ratio of 5.00 and a debt-to-equity ratio of 151.29. The stock has a market capitalization of $827.22 million, a P/E ratio of 18.25 and a beta of 0.27.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Recommended Stories
- Five stocks we like better than Biotest Aktiengesellschaft
- Stock Dividend Cuts Happen Are You Ready?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Following Congress Stock Trades
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
